Literature DB >> 31599360

From Clinical Trials to Bedside: the Use of Antihypertensives in Aged Individuals. Part 2: Approach to Treatment.

Michael E Ernst1,2, Eric J MacLaughlin3.   

Abstract

PURPOSE OF REVIEW: Use of antihypertensives in older adults can be complicated by the potential for undesired effects on comorbidities, adverse effects of the drugs, and overall medication burden. The purpose of this two-part review is to discuss contemporary issues encountered in the management of hypertension in aged individuals, with a particular focus on considerations for the individualization of treatment. In Part 2, we discuss the individualized approach to treating hypertension in the elderly. RECENT
FINDINGS: Achieving lower blood pressure goals in older adults has the potential to increase risks for complications such as hypotension and acute renal insufficiency, especially in those less healthy. Because elderly exhibit many different phenotypes, a one-size-fits-all approach to treatment goals and choice of antihypertensives is problematic. Many areas of uncertainty remain, including what the optimal goal blood pressure should be in frail or institutionalized elderly, whether there is an upper age limit for treatment initiation where benefits and risks overlap, and when de-escalation of antihypertensives should be considered. Hypertension is a major modifiable risk factor, and the benefits of treatment in lowering cardiovascular events are realized for most individuals, even at advanced ages. Areas of uncertainty in the management of hypertension in this group mandate a cautious, individualized approach to treatment which relies on careful assessment of biologic or phenotypic age, rather than chronologic age alone.

Entities:  

Keywords:  Aged; Antihypertensive agents; Elderly; Hypertension

Mesh:

Substances:

Year:  2019        PMID: 31599360     DOI: 10.1007/s11906-019-0988-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  17 in total

Review 1.  Better blood pressure control: how to combine drugs.

Authors:  M J Brown; J K Cruickshank; A F Dominiczak; G A MacGregor; N R Poulter; G I Russell; S Thom; B Williams
Journal:  J Hum Hypertens       Date:  2003-02       Impact factor: 3.012

2.  Applying the Systolic Blood Pressure Intervention Trial Results to Older Adults.

Authors:  Mark A Supiano; Jeff D Williamson
Journal:  J Am Geriatr Soc       Date:  2016-11-07       Impact factor: 5.562

Review 3.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

4.  Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial.

Authors:  Michelle C Odden; Carmen A Peralta; Dan R Berlowitz; Karen C Johnson; Jeffrey Whittle; Dalane W Kitzman; Srinivasan Beddhu; John W Nord; Vasilios Papademetriou; Jeff D Williamson; Nicholas M Pajewski
Journal:  JAMA Intern Med       Date:  2017-04-01       Impact factor: 21.873

5.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

Authors:  Jeff D Williamson; Mark A Supiano; William B Applegate; Dan R Berlowitz; Ruth C Campbell; Glenn M Chertow; Larry J Fine; William E Haley; Amret T Hawfield; Joachim H Ix; Dalane W Kitzman; John B Kostis; Marie A Krousel-Wood; Lenore J Launer; Suzanne Oparil; Carlos J Rodriguez; Christianne L Roumie; Ronald I Shorr; Kaycee M Sink; Virginia G Wadley; Paul K Whelton; Jeffrey Whittle; Nancy F Woolard; Jackson T Wright; Nicholas M Pajewski
Journal:  JAMA       Date:  2016-06-28       Impact factor: 56.272

6.  Blood pressure and 10-year mortality risk in the Milan Geriatrics 75+ Cohort Study: role of functional and cognitive status.

Authors:  Giulia Ogliari; Rudi G J Westendorp; Majon Muller; Daniela Mari; Erminio Torresani; Irene Felicetta; Tiziano Lucchi; Paolo D Rossi; Behnam Sabayan; Anton J M de Craen
Journal:  Age Ageing       Date:  2015-11       Impact factor: 10.668

Review 7.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

8.  No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over.

Authors:  Jane Warwick; Emanuela Falaschetti; Kenneth Rockwood; Arnold Mitnitski; Lutgarde Thijs; Nigel Beckett; Christopher Bulpitt; Ruth Peters
Journal:  BMC Med       Date:  2015-04-09       Impact factor: 8.775

Review 9.  Orthostatic Intolerance in Older Persons: Etiology and Countermeasures.

Authors:  Nandu Goswami; Andrew P Blaber; Helmut Hinghofer-Szalkay; Jean-Pierre Montani
Journal:  Front Physiol       Date:  2017-11-09       Impact factor: 4.566

Review 10.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

Authors:  M R Law; J K Morris; N J Wald
Journal:  BMJ       Date:  2009-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.